Issue of Charges not a Factor in Court Decision on Price Transparency

Last week, a federal court in the District of Columbia rejected arguments by the American Hospital Association (AHA) that the Price Transparency Rule slated to take effect Jan. 1, 2021 is invalid. 

While I was lucky enough to forecast that the lawsuit would fail, one can hardly gloat about successfully anticipating that the government will win litigation, since I suspect their batting average is around .900. There is a reason I don’t predict the results of litigation very often. While I wasn’t surprised by the outcome, the reason that I expected the government to win wasn’t discussed at all in the decision.   

The regulations were authorized by a section of the Patient Protection and Affordable Care Act (PPACA) now codified at 42 U.S.C. § 300gg-18(e). The law requires that “each hospital operating within the United States shall for each year establish (and update) and make public (in accordance with guidelines developed by the U.S. Department of Health and Human Services Secretary), a list of the hospital’s standard charges for items and services provided by the hospital …” 

The case rejects the three arguments raised by the AHA: that the regulation was arbitrary, that it unfairly compelled speech, in violation of the First Amendment, and finally, that it was inconsistent with the statutory requirement. That last argument focused on the idea that hospitals should merely be required to publish their chargemaster, rather than listing details about reimbursement paid by private insurers. The hospitals were arguing that details about contracts with insurance companies are secret, and sharing them will drive up prices. They also said Congress only expected a disclosure of the chargemaster.

I am surprised that the Court didn’t focus on the fact that the statute uses the term “charges,” plural. The Court’s decision spends a fair amount of time discussing how the chargemaster is a poor indication of the amount patients actually pay for hospital services. As we all know, most insurers have negotiated a reimbursement rate that represents a substantial discount from that chargemaster. The fact that the statute refers to multiple charges suggests to me that Congress understood this, and wanted hospitals to detail what they charge different payors. 

While the word “charges” didn’t factor in the decision, it is the focus of the balance of this article. The transparency regulations only apply to hospitals, but everyone reading this should understand how entering into contracts with different reimbursement rates for the same services can affect your ability to charge a patient or insurer with whom you have no contract. Absent an explicit agreement, the price for a healthcare service is determined by an implied contract. If a patient or insurer challenges your price, a judge will consider the reimbursement that the facility accepts from other patients and insurers. If your largest payors reimburse between $2,500 and $3,000 for a service, you shouldn’t expect someone without a contract to pay the list price of $5,000. 

The bottom line is that in a dispute about the reasonableness of your charges, the figure that appears on your claims is likely to be far less important than the rate paid by the majority of patients and their insurers. For that reason, I strongly encourage clients to avoid reimbursement models linked to steep discounts from billed charges. To get more information about healthcare pricing rules generally, as well as a short discussion of the transparency rule, please register for the Aug. 6 webinar.     

Facebook
Twitter
LinkedIn

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24